Cargando…

Sovateltide Mediated Endothelin B Receptors Agonism and Curbing Neurological Disorders

Neurological/neurovascular disorders constitute the leading cause of disability and the second leading cause of death globally. Major neurological/neurovascular disorders or diseases include cerebral stroke, Alzheimer’s disease, spinal cord injury, neonatal hypoxic-ischemic encephalopathy, and other...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ranjan, Amaresh K., Gulati, Anil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955091/ https://www.ncbi.nlm.nih.gov/pubmed/35328566 http://dx.doi.org/10.3390/ijms23063146

Ejemplares similares

Sovateltide (IRL-1620) activates neuronal differentiation and prevents mitochondrial dysfunction in adult mammalian brains following stroke
por: Ranjan, Amaresh K., et al.
Publicado: (2020)

Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke
por: Gulati, Anil, et al.
Publicado: (2021)

Endothelin Receptors, Mitochondria and Neurogenesis in Cerebral Ischemia
por: Gulati, Anil
Publicado: (2016)

Controls of Central and Peripheral Blood Pressure and Hemorrhagic/Hypovolemic Shock
por: Ranjan, Amaresh K., et al.
Publicado: (2023)

Advances in Therapies to Treat Neonatal Hypoxic-Ischemic Encephalopathy
por: Ranjan, Amaresh K., et al.
Publicado: (2023)

Role of adrenergic receptors in shock
por: Geevarghese, Mathew, et al.
Publicado: (2023)

Endothelin ET(B) Receptor-Mediated Astrocytic Activation: Pathological Roles in Brain Disorders
por: Koyama, Yutaka
Publicado: (2021)

Molecular mechanism of agonism and inverse agonism in ghrelin receptor
por: Qin, Jiao, et al.
Publicado: (2022)

Anti-apoptotic activity of ET(B) receptor agonist, IRL-1620, protects neural cells in rats with cerebral ischemia
por: Briyal, Seema, et al.
Publicado: (2019)

Author Correction: Anti-apoptotic activity of ET(B) receptor agonist, IRL-1620, protects neural cells in rats with cerebral ischemia
por: Briyal, Seema, et al.
Publicado: (2020)

Expression of Endothelin-1, Endothelin Receptor-A, and Endothelin Receptor-B in facial melasma compared to adjacent skin
por: da Silva, Carolina Nunhez, et al.
Publicado: (2023)

Biased agonism
por: Kenakin, Terry
Publicado: (2009)

Agonism and Antagonism at the Insulin Receptor
por: Knudsen, Louise, et al.
Publicado: (2012)

Neuroprotective Effect of IRL-1620, an Endothelin B Receptor Agonist, on a Pediatric Rat Model of Middle Cerebral Artery Occlusion
por: Cifuentes, Enrique G., et al.
Publicado: (2018)

Smoking particles enhance endothelin A and endothelin B receptor-mediated contractions by enhancing translation in rat bronchi
por: Granström, Bengt W, et al.
Publicado: (2006)

Centhaquine Restores Renal Blood Flow and Protects Tissue Damage After Hemorrhagic Shock and Renal Ischemia
por: Ranjan, Amaresh K., et al.
Publicado: (2021)

GLP-1/glucagon receptor co-agonism for treatment of obesity
por: Sánchez-Garrido, Miguel A., et al.
Publicado: (2017)

Kinetic basis of partial agonism at NMDA receptors
por: Kussius, Cassandra L, et al.
Publicado: (2009)

The Role of Endothelin-1 and Endothelin Receptor Antagonists in Inflammatory Response and Sepsis
por: Kowalczyk, Agata, et al.
Publicado: (2014)

Endotheliitis, endothelin, and endothelin receptor blockers in COVID-19
por: Sanghavi, Devang K., et al.
Publicado: (2021)

Structural insights into endothelin receptor signalling
por: Shihoya, Wataru, et al.
Publicado: (2023)

Roles of Astrocytic Endothelin ET(B) Receptor in Traumatic Brain Injury
por: Michinaga, Shotaro, et al.
Publicado: (2023)

Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and Progression
por: Giurini, Eileena F., et al.
Publicado: (2022)

Endothelin Receptor Antagonists in Kidney Disease
por: Martínez-Díaz, Irene, et al.
Publicado: (2023)

Insights into Endothelin Receptors in Pulmonary Hypertension
por: Liu, Ruiqi, et al.
Publicado: (2023)

Activation of neuronal endothelin B receptors mediates pressor response through alpha‐1 adrenergic receptors
por: Becker, Bryan K., et al.
Publicado: (2017)

Agonizing Hedgehog
por: Weitzman, Jonathan B
Publicado: (2002)

The therapeutic potential of GLP‐1 receptor biased agonism
por: Jones, Ben
Publicado: (2021)

PPARδ Agonism for the Treatment of Obesity and Associated Disorders: Challenges and Opportunities
por: Perreault, Mylène, et al.
Publicado: (2008)

Curbing Inflammation in Burn Patients
por: Farina, Jayme A., et al.
Publicado: (2013)

Agon : ballet for twelve dancers
por: Stravinsky, Igor, 1882-1971
Publicado: (1957)

The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion—A Review
por: Mathiesen, David S., et al.
Publicado: (2019)

Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease
por: Kim, Yaeni, et al.
Publicado: (2019)

Structural Insights into Ligand—Receptor Interactions Involved in Biased Agonism of G-Protein Coupled Receptors
por: Jóźwiak, Krzysztof, et al.
Publicado: (2021)

Endothelin inhibits renin release from juxtaglomerular cells via endothelin receptors A and B via a transient receptor potential canonical‐mediated pathway
por: Ortiz‐Capisano, M. Cecilia
Publicado: (2014)

Curbing Inflammation
por: Landis, R. Clive, et al.
Publicado: (2013)

Endothelin receptors as novel targets in tumor therapy
por: Bagnato, Anna, et al.
Publicado: (2004)

Structural determinants of dual incretin receptor agonism by tirzepatide
por: Sun, Bingfa, et al.
Publicado: (2022)

Endothelin Receptors and Their Antagonists()()
por: Maguire, Janet J., et al.
Publicado: (2015)

Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension
por: Tabeling, Christoph, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ummb7ef4lekn6bv9tp74opggcs